Evidence map›Paper›PMID 28255214›Full record

ArticleThe International journal of angiology : official publication of the International College of Angiology, Inc2017

Endothelial Progenitor Cells as a Marker of Endothelial Dysfunction and Atherosclerosis in Ankylosing Spondylitis: A Cross-Sectional Study.

Inderjeet Verma, Ashit Syngle, Pawan Krishan, Nidhi Garg

Open access · bronzeAbstract read
In one paragraph

Article in The International journal of angiology : official publication of the International College of Angiology, Inc, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Angiotensin-Receptor Blockade Improves Inflammation and Endothelial Dysfunction in Ankylosing Spondylitis: ARB-AS Study.The International journal of angiology : official publication of the International College of Angiology, Inc · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Inderjeet VermaDepartment of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India.
Ashit SyngleCardio Rheuma and Healing Touch City Clinic, Chandigarh and Consultant Rheumatologist Fortis Multi Specialty Hospital, Mohali, Chandigarh, India.
Pawan KrishanDepartment of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India.
Nidhi GargDepartment of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India.
Punjabi University · INTamil Nadu Government Multi Super Speciality Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial progenitor cells (EPCs) have reparative potential in overcoming the endothelial dysfunction and reducing cardiovascular risk. EPC depletion has been demonstrated in the setting of established atherosclerotic diseases. We evaluated whether reduced EPCs population are associated with endothelial dysfunction, subclinical atherosclerosis, and inflammatory markers in ankylosing spondylitis (AS) patients without any known traditional cardiovascular risk factor. We performed a cross-sectional study of 30 consecutive AS patients and 25 age- and sex-matched healthy controls. Patients with traditional cardiovascular risk factors were excluded. Circulating EPCs (CD34

Indexed as

ankylosing spondylitiscarotid intima-media thicknessendothelial functionendothelial progenitor cellsinflammation

Identifiers

PMID28255214
PMCPMC5330760
OpenAlexW2527964567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.